1 / 16

ADNI (N=587,critical P-value: 0.025)

Higher BMI (body mass index) is linked to greater brain atrophy in 700 MCI and AD patients, and in healthy elderly. (N=113, critical P-value: 0.011). ADNI (N=587,critical P-value: 0.025). Ho, Raji et al., Neurobiology of Aging, 2010.

hei
Download Presentation

ADNI (N=587,critical P-value: 0.025)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Higher BMI (body mass index) is linked to greater brain atrophyin 700 MCI and AD patients, and in healthy elderly (N=113, critical P-value: 0.011) ADNI (N=587,critical P-value: 0.025) Ho, Raji et al., Neurobiology of Aging, 2010

  2. Higher BMI associated with similar pattern of atrophy in the subgroup of 476 MCI subjects CHS, N=77; critical P-value: 0.009 ADNI N=400, critical P-value: 0.019 Ho and Raji et al., Neurobiology of Aging, 2010

  3. Surprisingly, this is still true in AD:Higher BMI is linked with more severe (~2%) brain volume reduction 188 AD patients Critical P-value: 0.012 Ho and Raji et al., Neurobiology of Aging, 2010

  4. AIM 1 Implications • First study to show that higher BMI is correlated with regional profiles of brain atrophy in both healthy and cognitively impaired persons • Results were reproduced in two independent samples • Strength of the BMI-brain atrophy relationship in healthy control, MCI, and AD emphasizes the need to consider obesity as risk modifying for cognitive impairment • Controlling body fat content even in late life may reduce risk for dementia (interventional studies are needed)

  5. Obesity-associated gene (FTO) relates to brain structure • Background: • FTO (fat mass and obesity-associated) gene highly expressed in the brain Frayling et al., 2007 • Carried by 46% of Western Europeans • BMI is highly genetically influenced (genetic factors explaining 50-90% of the variance in BMI) • Associated with a ~1.2 kg weight gain and ~1 cm waist circumference increase – carriers eat, on average, 200 more calories a day • Carriers (2 copies of the variant) were 67% more likely to be obese than non-carriers Frayling et al., 2007 • Used proxy (tagging SNP) that has 98.8% accuracy in predicting risk allele • PNAS paper (Ho 2010): this very common obesity-associated risk allele is associated with lower brain volume in similar areas affected by obesity • Study Design: Cross-sectional study using TBM in 206 ADNI controls (healthy elderly)

  6. Carriers of obesity risk allele, in FTO, have greater atrophyin frontal and occipital lobes (206 ADNI controls) Critical P=0.00131 Ho et al., PNAS, 2010

  7. Higher BMI associated with widespread pattern of atrophy Ho et al., PNAS, 2010 Critical P=0.0202

  8. White matter burden does not explain effect of FTO risk allele on brain atrophy (N=169) Critical P=0.0016 Ho et al., PNAS, 2010

  9. Depending on your FTO genotype, BMI seems to affect youin a different way 1 or 2 risk alleles N=128, critical P=0.016 2 risk alleles N=33; critical P=0.0022 1 risk allele N=95; critical P= 0.0113 *Does not pass FDR at 5% in non-carriers (N=78) Ho et al., PNAS 2010

  10. What can be done about this? We found that the level of atrophy was linked with high levels of homocysteine in the blood (N=732, all ADNI subjects) – vitamin B/folate supplements may reduce this RajagopalanNeuroReport2011

  11. Homocysteine levels in the blood explain a substantial proportion of brain atrophy (N=356 MCI subjects only) – dietary folate supplements may reduce this (testable in a trial) RajagopalanNeuroReport2011

  12. What else can be done about atrophy? Higher physical activity correlated with greater brain volume Ho and Raji et al., Human Brain Mapping, 2010 Critical P=0.0003

  13. What can be done about atrophy? Higher educational level is correlated with greater temporal lobe volume Ho and Raji et al., Human Brain Mapping, 2010 Critical P=0.0021

  14. Genome-wide association study Where in the genome is a common variant (carried by >1% of the population) associated with a brain measure? One SNP 600,000 SNPs P-value Caudate Volume Change Position along genome A/A C/C A/C Genotype GWAS = Finding common variants which explain the heritability of a trait.

  15. Discovered Genes for Caudate Volume - ADNI top hit (dopamine pathway gene) was replicated in young adults Stein Mol Psych 2011

  16. Replication through collaboration http://enigma.loni.ucla.edu 83 members from 9 countries, GWAS meta-analysis in 19 cohorts (N>7,000)

More Related